This project has received funding from the European Union’s Horizon 2020 research and innovation
programme under the Marie Skłodowska-Curie grant agreement No 734825.

Genetic and Small Molecule Modifiers of Lysosomal Function

LysoMod is a project that aims to innovate in the area of personalized medicine for disorders of lysosomal dysfunction. The project is funded by the Horizon 2020 - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE) program and it fosters collaboration and staff-exchange between highly complementary and multidisciplinary academic experts and non-academic partners.

This site was designed with the
.com
website builder. Create your website today.
Start Now